Press "Enter" to skip to content

Posts tagged as “UroToday”

SUO 2019: Evaluation of Biomarkers 4K Score, SelectMDx and ExoDx, PSAD, TRUS and MRI for the Detection of High-Grade Prostate Cancer – UroToday

Published 10th December 2019 by admin
admin 0
SUO 2019: Evaluation of Biomarkers 4K Score, SelectMDx and ExoDx, PSAD, TRUS and MRI for the Detection of High-Grade Prostate Cancer – UroToday

SUO 2019: Evaluation of Biomarkers 4K Score, SelectMDx and ExoDx, PSAD, TRUS and MRI for the Detection of High-Grade Prostate Cancer  UroToday “prostate cancer” – Google News

Laparoscopic radical prostatectomy compared to open radical prostatectomy: Comparison between surgical time, complications and length of hospital stay. – UroToday

Published 10th December 2019 by admin
admin 0
Laparoscopic radical prostatectomy compared to open radical prostatectomy: Comparison between surgical time, complications and length of hospital stay. – UroToday

Laparoscopic radical prostatectomy compared to open radical prostatectomy: Comparison between surgical time, complications and length of hospital stay.  UroToday “prostate cancer” – Google News

Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis. – UroToday

Published 10th December 2019 by admin
admin 0
Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis. – UroToday

Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis.  UroToday “prostate cancer” – Google News

Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy. – UroToday

Published 10th December 2019 by admin
admin 0
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy. – UroToday

Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy.  UroToday “prostate cancer” – Google News

The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study. – UroToday

Published 10th December 2019 by admin
admin 0
The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study. – UroToday

The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study.  UroToday “prostate cancer” – Google News

Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered A “Negative Core” in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis – Beyond the Abstract – UroToday

Published 9th December 2019 by admin
admin 0
Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered A “Negative Core” in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis – Beyond the Abstract – UroToday

Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered A “Negative Core” in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis – Beyond the Abstract  UroToday “prostate…

Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients with Oligo-Progression during Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience – Beyond the Abstract – UroToday

Published 9th December 2019 by admin
admin 0
Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients with Oligo-Progression during Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience – Beyond the Abstract – UroToday

Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients with Oligo-Progression during Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience – Beyond the Abstract  UroToday “prostate cancer” – Google News